These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 4172727

  • 1. Fibrinolysis.
    Sherry S.
    Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Fibrinolysis and thrombolytic therapy under laboratory control].
    Osten W.
    Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
    [No Abstract] [Full Text] [Related]

  • 6. [Thrombolytic treatment of thromboembolytic conditions].
    Gormsen J.
    Ugeskr Laeger; 1966 Oct 20; 128(42):1235-45. PubMed ID: 4231392
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC.
    Thromb Diath Haemorrh Suppl; 1973 Oct 20; 56():239-51. PubMed ID: 4617331
    [No Abstract] [Full Text] [Related]

  • 10. Fibrinolytic agents.
    Sherry S.
    Dis Mon; 1969 May 20; ():3-32. PubMed ID: 4241828
    [No Abstract] [Full Text] [Related]

  • 11. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M.
    Thromb Diath Haemorrh; 1970 Jun 30; 23(3):513-52. PubMed ID: 4247030
    [No Abstract] [Full Text] [Related]

  • 12. Perspectives: fibrinolysis and thrombolysis.
    Sherry S.
    Thromb Diath Haemorrh Suppl; 1966 Jun 30; 20():1-12. PubMed ID: 5973051
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolytic therapy.
    Gallus AS.
    Compr Ther; 1976 Apr 30; 2(4):67-73. PubMed ID: 131019
    [No Abstract] [Full Text] [Related]

  • 14. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Apr 30; 113(1-2):6-17. PubMed ID: 2427416
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The hematologic consequences of thrombolytic therapy.
    Fletcher AP, Alkjaersig NK.
    Prog Hematol; 1986 Apr 30; 14():183-200. PubMed ID: 2935903
    [No Abstract] [Full Text] [Related]

  • 17. [Contemporary data on the human fibrinolytic system].
    Andreenko GV.
    Klin Med (Mosk); 1970 Oct 30; 48(10):16-24. PubMed ID: 4252327
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
    Bielawiec M.
    Pol Tyg Lek; 1969 Jan 13; 24(2):63-6. PubMed ID: 4240415
    [No Abstract] [Full Text] [Related]

  • 20. Thrombolysis.
    Sharp AA.
    Adv Cardiol; 1970 Jan 13; 4():225-32. PubMed ID: 4250170
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.